Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy

Natriuretic peptides in cardiometabolic regulation and disease

(2014) Nora E. Zois et al.   Nature Reviews Cardiology

The heart as an endocrine organ

(2014) Tsuneo Ogawa et al.   Endocrine Connections

Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicity

(2013) Nicola Ferri et al.   PHARMACOLOGY & THERAPEUTICS

Cardiac Troponins in Young Marathon Runners

(2012) Natthapon Traiperm et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists

(2012) Sayuri N. Friedland et al.   AMERICAN JOURNAL OF MEDICINE

Troponin I measured with a high sensitivity immunoassay is significantly increased after a half marathon run

(2012) Giuseppe Lippi et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

(2011) HG Laverty et al.   BRITISH JOURNAL OF PHARMACOLOGY

Human Pro-B-Type Natriuretic Peptide Is Processed in the Circulation in a Rat Model

(2011) A. G. Semenov et al.   CLINICAL CHEMISTRY

The impact of exercise intensity on the release of cardiac biomarkers in marathon runners

(2011) Alejandro Legaz-Arrese et al.   EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY

Morphologic Aspects of Rodent Cardiotoxicity in a Retrospective Evaluation of National Toxicology Program Studies

(2011) Micheal P. Jokinen et al.   TOXICOLOGIC PATHOLOGY

The Complete Pharmacokinetic Profile of Serum Cardiac Troponin I in the Rat and the Dog

(2011) Michael E. Dunn et al.   TOXICOLOGICAL SCIENCES

Temporal association of elevations in serum cardiac troponin T and myocardial oxidative stress after prolonged exercise in rats

(2010) Jinlei Nie et al.   EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY

Detection of Left Ventricular Hypertrophy in Rats Administered a Peroxisome Proliferator–Activated Receptor α/γ Dual Agonist Using Natriuretic Peptides and Imaging

(2010) Steven K. Engle et al.   TOXICOLOGICAL SCIENCES

The future of drug safety testing: expanding the view and narrowing the focus

(2009) James L. Stevens et al.   DRUG DISCOVERY TODAY

Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone

(2009) Fahim Abbasi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Longitudinal Studies of Cardiac Troponin-I Concentrations in Serum from Male Sprague Dawley Rats: Baseline Reference Ranges and Effects of Handling and Placebo Dosing on Biological Variability

(2009) A. Eric Schultze et al.   TOXICOLOGIC PATHOLOGY

Effects of Chronic PPAR-Agonist Treatment on Cardiac Structure and Function, Blood Pressure, and Kidney in Healthy Sprague-Dawley Rats

(2009) Eileen R. Blasi et al.   PPAR Research

Thiazolidinediones and the renal and hormonal response to water immersion-induced volume expansion in type 2 diabetes mellitus

(2008) Niru Goenka et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists

(2008) H.-R. Liu et al.   CARDIOVASCULAR RESEARCH

Analytical Characteristics of Commercial Cardiac Troponin I and T Immunoassays in Serum from Rats, Dogs, and Monkeys with Induced Acute Myocardial Injury

(2008) F. S. Apple et al.   CLINICAL CHEMISTRY